 | • レポートコード：QYR2104Z4305 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、口腔粘膜炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法）、用途別市場規模（病院、歯科医院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・口腔粘膜炎治療薬の市場動向 ・企業の競争状況、市場シェア ・口腔粘膜炎治療薬の種類別市場規模（化学療法、放射線療法） ・口腔粘膜炎治療薬の用途別市場規模（病院、歯科医院、その他） ・口腔粘膜炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・口腔粘膜炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・口腔粘膜炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・口腔粘膜炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・口腔粘膜炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（3M Healthcare、GSK、Pfizer、Colgate-Palmolive、Norgine、Biovitrum、Bausch Health、EUSA Pharma、Camurus、Mission Pharmacal、Clinigen Group、Midatech Pharma、Alliance Pharma、AMAG Pharmaceuticals） ・結論 |
Oral mucositis (OM) is the inflammation of oral mucosa and is manifested by pain and erythema or ulcerations. This condition is generally seen as a complication due to side effects of chemotherapy and radiotherapy in cancer patients. The systemic effects of cytotoxic chemotherapy agents and radiation effects on oral mucosa led to oral mucositis.
North America is the largest market for OM therapeutics, closely followed by the European region.
Market Analysis and Insights: Global Oral Mucositis Therapeutics Market
The global Oral Mucositis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Mucositis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Mucositis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Mucositis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Mucositis Therapeutics market.
Global Oral Mucositis Therapeutics Scope and Market Size
Oral Mucositis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Mucositis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiotherapy
Segment by Application
Hospitals
Dental Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Bausch Health
EUSA Pharma
Camurus
Colgate-Palmolive
Norgine
Midatech Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Mucositis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.3 Market by Application
1.3.1 Global Oral Mucositis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Dental Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Mucositis Therapeutics Market Perspective (2016-2027)
2.2 Oral Mucositis Therapeutics Growth Trends by Regions
2.2.1 Oral Mucositis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Mucositis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Oral Mucositis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Oral Mucositis Therapeutics Industry Dynamic
2.3.1 Oral Mucositis Therapeutics Market Trends
2.3.2 Oral Mucositis Therapeutics Market Drivers
2.3.3 Oral Mucositis Therapeutics Market Challenges
2.3.4 Oral Mucositis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Mucositis Therapeutics Players by Revenue
3.1.1 Global Top Oral Mucositis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Oral Mucositis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Oral Mucositis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Mucositis Therapeutics Revenue
3.4 Global Oral Mucositis Therapeutics Market Concentration Ratio
3.4.1 Global Oral Mucositis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Mucositis Therapeutics Revenue in 2020
3.5 Oral Mucositis Therapeutics Key Players Head office and Area Served
3.6 Key Players Oral Mucositis Therapeutics Product Solution and Service
3.7 Date of Enter into Oral Mucositis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Mucositis Therapeutics Breakdown Data by Type
4.1 Global Oral Mucositis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Oral Mucositis Therapeutics Forecasted Market Size by Type (2022-2027)
5 Oral Mucositis Therapeutics Breakdown Data by Application
5.1 Global Oral Mucositis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Oral Mucositis Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oral Mucositis Therapeutics Market Size (2016-2027)
6.2 North America Oral Mucositis Therapeutics Market Size by Type
6.2.1 North America Oral Mucositis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Oral Mucositis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Oral Mucositis Therapeutics Market Size by Type (2016-2027)
6.3 North America Oral Mucositis Therapeutics Market Size by Application
6.3.1 North America Oral Mucositis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Oral Mucositis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Oral Mucositis Therapeutics Market Size by Application (2016-2027)
6.4 North America Oral Mucositis Therapeutics Market Size by Country
6.4.1 North America Oral Mucositis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Oral Mucositis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oral Mucositis Therapeutics Market Size (2016-2027)
7.2 Europe Oral Mucositis Therapeutics Market Size by Type
7.2.1 Europe Oral Mucositis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Oral Mucositis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Oral Mucositis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Oral Mucositis Therapeutics Market Size by Application
7.3.1 Europe Oral Mucositis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Oral Mucositis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Oral Mucositis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Oral Mucositis Therapeutics Market Size by Country
7.4.1 Europe Oral Mucositis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Oral Mucositis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oral Mucositis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Oral Mucositis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Oral Mucositis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Mucositis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Mucositis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Mucositis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Oral Mucositis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Mucositis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Mucositis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Mucositis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Oral Mucositis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Mucositis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Mucositis Therapeutics Market Size (2016-2027)
9.2 Latin America Oral Mucositis Therapeutics Market Size by Type
9.2.1 Latin America Oral Mucositis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Oral Mucositis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Oral Mucositis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Oral Mucositis Therapeutics Market Size by Application
9.3.1 Latin America Oral Mucositis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Oral Mucositis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Oral Mucositis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Oral Mucositis Therapeutics Market Size by Country
9.4.1 Latin America Oral Mucositis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Oral Mucositis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Mucositis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Oral Mucositis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Oral Mucositis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Mucositis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Mucositis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Mucositis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Oral Mucositis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Mucositis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Mucositis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Mucositis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Oral Mucositis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Mucositis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 3M Healthcare
11.1.1 3M Healthcare Company Details
11.1.2 3M Healthcare Business Overview
11.1.3 3M Healthcare Oral Mucositis Therapeutics Introduction
11.1.4 3M Healthcare Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.1.5 3M Healthcare Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Oral Mucositis Therapeutics Introduction
11.2.4 GSK Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral Mucositis Therapeutics Introduction
11.3.4 Pfizer Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Colgate-Palmolive
11.4.1 Colgate-Palmolive Company Details
11.4.2 Colgate-Palmolive Business Overview
11.4.3 Colgate-Palmolive Oral Mucositis Therapeutics Introduction
11.4.4 Colgate-Palmolive Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.4.5 Colgate-Palmolive Recent Development
11.5 Norgine
11.5.1 Norgine Company Details
11.5.2 Norgine Business Overview
11.5.3 Norgine Oral Mucositis Therapeutics Introduction
11.5.4 Norgine Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.5.5 Norgine Recent Development
11.6 Biovitrum
11.6.1 Biovitrum Company Details
11.6.2 Biovitrum Business Overview
11.6.3 Biovitrum Oral Mucositis Therapeutics Introduction
11.6.4 Biovitrum Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.6.5 Biovitrum Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Oral Mucositis Therapeutics Introduction
11.7.4 Bausch Health Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.7.5 Bausch Health Recent Development
11.8 EUSA Pharma
11.8.1 EUSA Pharma Company Details
11.8.2 EUSA Pharma Business Overview
11.8.3 EUSA Pharma Oral Mucositis Therapeutics Introduction
11.8.4 EUSA Pharma Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.8.5 EUSA Pharma Recent Development
11.9 Camurus
11.9.1 Camurus Company Details
11.9.2 Camurus Business Overview
11.9.3 Camurus Oral Mucositis Therapeutics Introduction
11.9.4 Camurus Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.9.5 Camurus Recent Development
11.10 Mission Pharmacal
11.10.1 Mission Pharmacal Company Details
11.10.2 Mission Pharmacal Business Overview
11.10.3 Mission Pharmacal Oral Mucositis Therapeutics Introduction
11.10.4 Mission Pharmacal Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.10.5 Mission Pharmacal Recent Development
11.11 Clinigen Group
11.11.1 Clinigen Group Company Details
11.11.2 Clinigen Group Business Overview
11.11.3 Clinigen Group Oral Mucositis Therapeutics Introduction
11.11.4 Clinigen Group Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.11.5 Clinigen Group Recent Development
11.12 Midatech Pharma
11.12.1 Midatech Pharma Company Details
11.12.2 Midatech Pharma Business Overview
11.12.3 Midatech Pharma Oral Mucositis Therapeutics Introduction
11.12.4 Midatech Pharma Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.12.5 Midatech Pharma Recent Development
11.13 Alliance Pharma
11.13.1 Alliance Pharma Company Details
11.13.2 Alliance Pharma Business Overview
11.13.3 Alliance Pharma Oral Mucositis Therapeutics Introduction
11.13.4 Alliance Pharma Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.13.5 Alliance Pharma Recent Development
11.14 AMAG Pharmaceuticals
11.14.1 AMAG Pharmaceuticals Company Details
11.14.2 AMAG Pharmaceuticals Business Overview
11.14.3 AMAG Pharmaceuticals Oral Mucositis Therapeutics Introduction
11.14.4 AMAG Pharmaceuticals Revenue in Oral Mucositis Therapeutics Business (2016-2021)
11.14.5 AMAG Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oral Mucositis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Global Oral Mucositis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Oral Mucositis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Mucositis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Oral Mucositis Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Oral Mucositis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Oral Mucositis Therapeutics Market Share by Regions (2022-2027)
Table 10. Oral Mucositis Therapeutics Market Trends
Table 11. Oral Mucositis Therapeutics Market Drivers
Table 12. Oral Mucositis Therapeutics Market Challenges
Table 13. Oral Mucositis Therapeutics Market Restraints
Table 14. Global Oral Mucositis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Oral Mucositis Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Oral Mucositis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Mucositis Therapeutics as of 2020)
Table 17. Ranking of Global Top Oral Mucositis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Oral Mucositis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oral Mucositis Therapeutics Product Solution and Service
Table 21. Date of Enter into Oral Mucositis Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral Mucositis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Oral Mucositis Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Oral Mucositis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Oral Mucositis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Oral Mucositis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Oral Mucositis Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Oral Mucositis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Oral Mucositis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Oral Mucositis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Oral Mucositis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Oral Mucositis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Oral Mucositis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Oral Mucositis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Oral Mucositis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Oral Mucositis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Oral Mucositis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Oral Mucositis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Oral Mucositis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Oral Mucositis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Oral Mucositis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Oral Mucositis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Oral Mucositis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oral Mucositis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oral Mucositis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oral Mucositis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Oral Mucositis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Oral Mucositis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Oral Mucositis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Oral Mucositis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Oral Mucositis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Oral Mucositis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Oral Mucositis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Oral Mucositis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Oral Mucositis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oral Mucositis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oral Mucositis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oral Mucositis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Oral Mucositis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. 3M Healthcare Company Details
Table 62. 3M Healthcare Business Overview
Table 63. 3M Healthcare Oral Mucositis Therapeutics Product
Table 64. 3M Healthcare Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 65. 3M Healthcare Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Oral Mucositis Therapeutics Product
Table 69. GSK Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Oral Mucositis Therapeutics Product
Table 74. Pfizer Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Colgate-Palmolive Company Details
Table 77. Colgate-Palmolive Business Overview
Table 78. Colgate-Palmolive Oral Mucositis Therapeutics Product
Table 79. Colgate-Palmolive Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Colgate-Palmolive Recent Development
Table 81. Norgine Company Details
Table 82. Norgine Business Overview
Table 83. Norgine Oral Mucositis Therapeutics Product
Table 84. Norgine Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Norgine Recent Development
Table 86. Biovitrum Company Details
Table 87. Biovitrum Business Overview
Table 88. Biovitrum Oral Mucositis Therapeutics Product
Table 89. Biovitrum Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Biovitrum Recent Development
Table 91. Bausch Health Company Details
Table 92. Bausch Health Business Overview
Table 93. Bausch Health Oral Mucositis Therapeutics Product
Table 94. Bausch Health Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Bausch Health Recent Development
Table 96. EUSA Pharma Company Details
Table 97. EUSA Pharma Business Overview
Table 98. EUSA Pharma Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 99. EUSA Pharma Recent Development
Table 100. Camurus Company Details
Table 101. Camurus Business Overview
Table 102. Camurus Oral Mucositis Therapeutics Product
Table 103. Camurus Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Camurus Recent Development
Table 105. Mission Pharmacal Company Details
Table 106. Mission Pharmacal Business Overview
Table 107. Mission Pharmacal Oral Mucositis Therapeutics Product
Table 108. Mission Pharmacal Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Mission Pharmacal Recent Development
Table 110. Clinigen Group Company Details
Table 111. Clinigen Group Business Overview
Table 112. Clinigen Group Oral Mucositis Therapeutics Product
Table 113. Clinigen Group Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Clinigen Group Recent Development
Table 115. Midatech Pharma Company Details
Table 116. Midatech Pharma Business Overview
Table 117. Midatech Pharma Oral Mucositis Therapeutics Product
Table 118. Midatech Pharma Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Midatech Pharma Recent Development
Table 120. Alliance Pharma Company Details
Table 121. Alliance Pharma Business Overview
Table 122. Alliance Pharma Oral Mucositis Therapeutics Product
Table 123. Alliance Pharma Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Alliance Pharma Recent Development
Table 125. AMAG Pharmaceuticals Company Details
Table 126. AMAG Pharmaceuticals Business Overview
Table 127. AMAG Pharmaceuticals Oral Mucositis Therapeutics Product
Table 128. AMAG Pharmaceuticals Revenue in Oral Mucositis Therapeutics Business (2016-2021) & (US$ Million)
Table 129. AMAG Pharmaceuticals Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Mucositis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Global Oral Mucositis Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Dental Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Oral Mucositis Therapeutics Report Years Considered
Figure 9. Global Oral Mucositis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Oral Mucositis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Oral Mucositis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Oral Mucositis Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Oral Mucositis Therapeutics Market Share by Players in 2020
Figure 14. Global Top Oral Mucositis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Mucositis Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Oral Mucositis Therapeutics Revenue in 2020
Figure 16. Global Oral Mucositis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Oral Mucositis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Oral Mucositis Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Oral Mucositis Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Oral Mucositis Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oral Mucositis Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Oral Mucositis Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Oral Mucositis Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oral Mucositis Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Oral Mucositis Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Oral Mucositis Therapeutics Market Share by Region (2016-2027)
Figure 38. China Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oral Mucositis Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Oral Mucositis Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Oral Mucositis Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oral Mucositis Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Oral Mucositis Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Oral Mucositis Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Oral Mucositis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. 3M Healthcare Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 58. GSK Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 60. Colgate-Palmolive Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 61. Norgine Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 62. Biovitrum Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 63. Bausch Health Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 64. EUSA Pharma Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 65. Camurus Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 66. Mission Pharmacal Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 67. Clinigen Group Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 68. Midatech Pharma Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 69. Alliance Pharma Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 70. AMAG Pharmaceuticals Revenue Growth Rate in Oral Mucositis Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の口腔粘膜炎市場規模・現状・予測（2021年-2027年） Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body…- 世界の口腔粘膜炎市場規模・現状・予測（2021年-2027年） Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body…
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…